The conversation surrounding kratom has changed dramatically in recent years. While traditional kratom leaf has long been marketed as an herbal supplement for pain relief and increased energy, a new generation of highly concentrated products containing 7-hydroxymitragynine (7-OH) has raised considerable concerns among healthcare professionals and regulators. As these more potent products become increasingly available, experts are warning that they may carry a much greater risk of dependence and addiction than traditional kratom.
How Does Kratom Lead to Addiction?
As a botanical substance derived from the leaves of the Mitragyna speciosa tree, it acts on opioid receptors in the brain, although its pharmacology differs from prescription opioids. At lower doses, kratom is commonly associated with stimulating effects, including increased energy, alertness, and focus. As the dose increases, its effects become more opioid-like, often producing relaxation, pain relief, drowsiness, and feelings of euphoria.
Repeated exposure can cause the brain to adapt to the drug’s presence. Over time, many users develop tolerance, meaning they must take increasingly larger amounts to achieve the same effects. As tolerance increases, physical dependence may develop, making it difficult to stop using kratom without experiencing withdrawal symptoms.
While not everyone who uses kratom becomes addicted, the risk increases with daily use, escalating doses, and the use of concentrated extracts or purified alkaloids.
Why Are 7-OH Products More Addictive?
Naturally occurring kratom contains only tiny amounts of 7-OH. However, manufacturers now produce tablets, gummies, liquid shots, capsules, powders, and drink additives containing highly concentrated or chemically enhanced amounts of this compound.
Because these products deliver much higher concentrations than occur naturally—up to 50% more, in fact—they produce stronger activation of opioid receptors. Users often experience more intense euphoria and pain relief, but these stronger effects also accelerate tolerance, increase physical dependence, and make addiction more likely.
Recognizing these risks, the U.S. Drug Enforcement Administration announced in July 2026 that it would temporarily place concentrated 7-OH products above specified thresholds, along with several related substances, into Schedule I under the Controlled Substances Act. According to the DEA, these products present an imminent hazard to public health because of their high potential for abuse and their opioid-like effects. The agency emphasized that its action targets concentrated 7-OH products and related synthetic substances rather than traditional botanical kratom itself.
Iowa’s Changing Legal Landscape Regarding Kratom and 7-OH Products
In March 2026, the Iowa House passed legislation that would classify kratom as a Schedule I controlled substance under state law, reflecting lawmakers’ concerns about abuse potential and the growing market for high-potency kratom-derived products. Although legislative proposals must complete the full lawmaking process before becoming law, the bill illustrates Iowa’s increasingly cautious approach to kratom regulation.
Educational guidance distributed by Iowa prevention and treatment organizations has likewise highlighted the important distinction between traditional kratom and concentrated 7-OH products. The guidance notes that concentrated 7-OH products may present significantly greater health risks because of their increased potency and stronger opioid-like effects, aligning with recent federal enforcement efforts.
What Are the Signs of 7-OH or Kratom Addiction?
Many people don’t recognize that drug dependence gradually moves through key stages. Someone may begin using kratom occasionally for pain or energy, only to find themselves relying on it every day just to function normally. Common signs of kratom or 7-OH addiction include:
- Taking larger doses than originally intended.
- Needing progressively more kratom or 7-OH to achieve the same effects.
- Experiencing intense cravings or constantly thinking about the next dose.
- Feeling unable to reduce or stop use despite repeated attempts.
- Spending significant amounts of time obtaining, using, or recovering from the substance.
- Continuing to use despite problems at work, school, or home.
- Withdrawing from hobbies, family activities, or social relationships.
- Using shortly after waking to avoid withdrawal symptoms.
- Continuing use despite worsening anxiety, depression, digestive problems, or other health concerns.
Someone with a dependency on concentrated 7-OH products often experiences these symptoms more rapidly because of the products’ greater potency.
Typical Withdrawal Symptoms
Suddenly stopping the use of kratom or 7-OH products often prompts withdrawal symptoms within hours that last several days or longer. These include, but aren’t limited to:
- Anxiety
- Irritability
- Restlessness
- Insomnia
- Muscle aches
- Sweating
- Chills
- Nausea
- Vomiting
- Diarrhea
- Tremors
- Fatigue
- Depressed mood
- Strong cravings
Some people also report difficulty concentrating and intense emotional distress as their bodies adjust to stopping the substance. Because concentrated 7-OH products act more powerfully on opioid receptors, the symptoms that occur after discontinuing use may be more severe than those experienced after stopping traditional kratom leaf products.
Discover Effective Kratom Addiction Treatment in Iowa at Ivory Plains
As Iowa considers stricter regulation and federal authorities increase oversight of concentrated 7-OH products, public awareness remains essential. Understanding the difference between traditional kratom and highly concentrated 7-OH products—and recognizing the early signs of addiction—helps individuals seek quality care before dependence becomes a more severe substance use disorder.
At Ivory Plains’ inclusive addiction rehabilitation program in Adair, Iowa, our board-certified professionals develop a continuum of care plan that reflects your individual needs. Recovery often begins with a comprehensive evaluation to determine the severity of dependence and whether medical supervision is appropriate during withdrawal. For someone dependent on highly concentrated 7-OH products, professional medical guidance is especially important because withdrawal symptoms may be more intense and relapse risk may be higher.
You or a loved one’s evidence-based treatment may include medically supervised detoxification, individual counseling, different types of therapy methods, peer recovery support, and more. Talk to a member of our admissions team today to learn how we can help.
